Final Volume 13, Number 1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Behavioral Neuroscience Uab Graduate Handbook
Behavioral Neuroscience Ph.D. Program Policies, Guidelines, & Procedures Student Handbook 2021-2022 University of Alabama at Birmingham Table of Contents Mission Statement __________________________________________ 3 History of the Program _______________________________________ 3 Policies and Procedures ______________________________________ 4 Overview of Student Career ___________________________________ 5 Typical Courses ____________________________________________ 5 Progress Reports ___________________________________________ 6 2nd Year Research Project __________________________________ 7 Qualifying Examination _______________________________________ 8 Dissertation ________________________________________________ 10 Behavioral Neuroscience Student Checklist _______________________ 13 Master’s Degree ____________________________________________ 15 Policies Regarding Adequate Progress __________________________ 16 Policies on Remunerated Activities _____________________________ 16 Vacation, Leave, Holiday Guidelines ____________________________ 17 Degree Requirements and Associated Procedures ________________ 18 2 BEHAVIORAL NEUROSCIENCE PROGRAM Mission Statement and History of the Program Mission Statement Behavioral neuroscience is represented by scientists with interests in the physiological and neural substrates of behavior. The mission of the Behavioral Neuroscience Ph.D. program is to produce outstanding young scientists capable of pursuing independent research careers in the field of behavioral neuroscience by providing graduate -
Introduction to Psychopharmacology
1 Introduction to Psychopharmacology CHAPTER OUTLINE • Psychopharmacology • Why Read a Book on Psychopharmacology? • Drugs: Administered Substances That Alter Physiological Functions • Psychoactive Drugs: Described by Manner of Use • Generic Names, Trade Names, Chemical Names, and Street Names for Drugs • Drug Effects: Determined by Dose • Pharmacology: Pharmacodynamics, Pharmacokinetics, and Pharmacogenetics • Psychoactive Drugs: Objective and Subjective Effects • Study Designs and the Assessment of Psychoactive Drugs • Validity: Addressing the Quality and Impact of an Experiment • Animals and Advancing Medical Research • Researchers Consider Many Ethical Issues When Conducting Human Research • From Actions to Effects: Therapeutic Drug Development • Chapter Summary sychoactive substances have made an enormous impact on society. Many people regularly drink alcohol or smoke tobacco. Millions of Americans take P prescribed drugs for depression or anxiety. As students, scholars, practitioners, and everyday consumers, we may find that learning about psychoactive substances can be invaluable. The chapters in this book provide a thorough overview of the Domajor not classes of psychoactive copy, drugs, including post, their actions inor the body distributeand their effects on behavior. 1 Copyright ©2018 by SAGE Publications, Inc. This work may not be reproduced or distributed in any form or by any means without express written permission of the publisher. 2 Drugs and the Neuroscience of Behavior Psychopharmacology Psychopharmacology Psychopharmacology is the study of how drugs affect mood, perception, think- Study of how drugs ing, or behavior. Drugs that achieve these effects by acting in the nervous system affect mood, perception, thinking, or behavior are called psychoactive drugs. The term psychopharmacology encompasses two large fields: psychology and pharmacology. Thus, psychopharmacology attempts to Psychoactive drugs Drugs that affect mood, relate the actions and effects of drugs to psychological processes. -
From Sacred Plants to Psychotherapy
From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine). -
Behavioral Epigenetics and the Developmental Origins of Child Mental Health Disorders
Journal of Developmental Origins of Health and Disease (2012), 3(6), 395–408. REVIEW & Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2012 doi:10.1017/S2040174412000426 Behavioral epigenetics and the developmental origins of child mental health disorders B. M. Lester1,2,3,4*, C. J. Marsit5, E. Conradt1,4, C. Bromer6 and J. F. Padbury3,4 1Brown Center for the Study of Children at Risk at Women and Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, RI, USA 2Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA 3Department of Pediatrics, Warren Alpen Medical School of Brown University, Providence, RI, USA 4Department of Pediatrics, Women and Infants Hospital of Rhode Island, Providence, RI, USA 5Departments of Pharmacology & Toxicology and Community & Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, USA 6Department of Neuroscience, Brown University, Providence, RI, USA Advances in understanding the molecular basis of behavior through epigenetic mechanisms could help explain the developmental origins of child mental health disorders. However, the application of epigenetic principles to the study of human behavior is a relatively new endeavor. In this paper we discuss the ‘Developmental Origins of Health and Disease’ including the role of fetal programming. We then review epigenetic principles related to fetal programming and the recent application of epigenetics to behavior. We focus on the neuroendocrine system and develop a simple heuristic stress-related model to illustrate how epigenetic changes in placental genes could predispose the infant to neurobehavioral profiles that interact with postnatal environmental factors potentially leading to mental health disorders. -
Psychologist Scope of Practice
The Honorable Eileen Cody 303 John L. O’Brien Building Olympia, WA 98504 April 23, 2020 The Honorable John Wiesman Secretary of Health Washington State Department of Health P.O. Box 47890 Olympia, Washington 98504-7890 Dear Secretary Wiesman, I am requesting that the Department of Health consider a Sunrise Review application for a proposal that would change the scope of practice for psychologists, namely giving this profession prescriptive authority for those with appropriate training. A copy of the proposal is attached for HB 2967 (2020). The House Health Care & Wellness Committee would be interested in an assessment of whether the proposal meets the sunrise criteria for expanding the scope of practice for a regulated health profession in Washington. I appreciate your consideration of this application and I look forward to receiving your report. Please contact my office if you have any questions. Sincerely, Representative Eileen Cody, RN Chair, House Health Care & Wellness Committee 34th Legislative District Cc: Kelly Cooper, Washington State Department of Health Melanie Smith, Washington State Psychological Association Representative Nicole Macri, 43rd Legislative District H-3313.2 HOUSE BILL 2967 State of Washington 66th Legislature 2020 Regular Session By Representative Macri 1 AN ACT Relating to the prescriptive authority of psychologists; 2 amending RCW 18.83.010, 18.83.050, 18.83.080, and 18.83.090; 3 reenacting and amending RCW 18.64.011, 18.79.260, and 69.50.101; and adding new sections to chapter 18.83 RCW.4 5 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON: 6 Sec. 1. -
Clinical Health Psychology Fellowship
Clinical Health Psychology Fellowship APA-ACCREDITED CLINICAL HEALTH PSYCHOLOGY FELLOWSHIP AT THE MAYO CLINIC APA-Accredited Clinical Health Psychology Fellowship at the Mayo Clinic The Clinical Health Psychology Fellowship is one of three tracks offered in the Medical Psychology Post-Doctoral Fellowship at Mayo Clinic. This APA-Accredited Fellowship is the Department of Psychiatry and Psychology, which is one of the largest psychiatric treatment groups in the United States, with more than 80 psychologists and psychiatrists. The two-year fellowship includes clinical activities, 30% protected time for research, educational activities, as well as opportunities for teaching/leadership. The Clinical Health Psychology Fellowship offers both breadth and depth in health psychology training. Fellows choose a specialty area (“major rotation”) in which they focus the majority of their clinical and research work. Fellows receive their clinical supervision and research mentorship in their specialty area. In addition, fellows can obtain broad training through several minor rotations. The rotational schedule is flexible based on the fellows’ interests and goals. All major rotation areas are also offered as minor rotations. “Fellows are able to complete minor rotations in each specialty area during the two-year fellowship, or they may choose to focus on their major area of concentration.” Many of our faculty hold leadership positions in the department and the institution, offering our fellows formal and informal professional development opportunities to learn about the role of the Clinical Health Psychologist within an academic medical center setting. Our faculty includes individuals from diverse cultural and clinical training backgrounds. We strongly encourage diverse applicants to apply to our program, including international applicants. -
Behavioral Neuroscience and Psychopharmacology
Behavioral Neuroscience and Psychopharmacology The Behavioral Neuroscience and Psychopharmacology area of concentration is designed to train students broadly in the general theoretical principles and technical approaches used to investigate the neurobehavioral mechanisms of alcohol and drug abuse. Psychopharmacological approaches to understanding basic principles of learning are also emphasized. Students receive a concentrated lab experience using either animal models (quail, mice or rats) or human subjects. Faculty in the program use different levels of analysis including cell culture models, neurochemical assays, developmental toxicology, classical conditioning of drug effects, operant conditioning, human behavioral pharmacology, and cognitive approaches to behavior. Students are expected to receive in depth training in at least one level of analysis although training that integrates more than one level of analysis is strongly encouraged. PROGRAM REQUIREMENTS COURSE REQUIREMENTS (1) Statistics sequence: PSY 610 - Experimental design PSY 611 - Correlational design (2) PSY 780 - Directed BNP studies PSY 780A - first year students only PSY 780B - first year and beyond (3) Any three proseminars selected from the following areas: Learning Cognitive processes Developmental Psychology Sensation & Perception Physiological Psychology (4) Four electives (a minimum of one of these must be outside of the Psychology Department) (see listing of some possible options on page **). (5) Additional course work as recommended by the advisory committee RESEARCH REQUIREMENTS It is expected that all students in the BNP area will be involved in research thorough out their course of study towards the Ph.D. The area has two formalized requirements that are designed to train the student in conducting research: (1) Master's thesis (2) Dissertation ALLIED AREA REQUIREMENT Each student is expected to develop an allied area to gain expertise in some area outside of the student's main research specialty. -
Handbook of Psychopharmacology
Handbook of Psychopharmacology Volume 7 Principles of Behavioral Pharmacology Handbook of Psychopharmacology SECTION I: BASIC NEUROPHARMACOLOGY Volume 1 Biochemical Principles and Techniques in Neuropharmacology Volume 2 Principles of Receptor Research Volume 3 Biochemistry of Biogenic Amines Volume 4 Amino Acid Neurotransmitters Volume 5 Synaptic Modulators Volume 6 Biogenic Amine Receptors SECTION II: BEHAVIORAL PHARMACOLOGY IN ANIMALS Volume 7 Principles of Behavioral Pharmacology Volume 8 Drugs, Neurotransmitters, and Behavior Volume 9 Chemical Pathways in the Brain SECTION III: HUMAN PSYCHOPHARMACOLOGY Volume 10 N euro leptics and Schizophrenia Volume 11 Stimulants Volume 12 Drugs of Abuse Volume 13 Biology of Drug Effects in Affective Disorders Volume 14 Anxiety and Affective Disorders: Drug Actions in Man Volume 7 Principles of Behavioral Pharmacology Edited by Leslie L. Iversen Department of Pharmacology University of Cambridge Susan D. Iversen Department of Psychology University of Cambridge and Solomon H. Snyder Departments of Pharmacology and Psychiatry The Johns Hopkins University School of Medicine PLENUM PRESS • NEW YORK AND LONDON Library of Congress Cataloging in Publication Data Main entry under title: Handbook of psychopharmacology. Includes bibliographies and indexes. CONTENTS: v. 1. Biochemical principles and techniques in neuropharmacology. -v. 2. Principles of receptor research.-v. 3. Biochemistry of biogenic amines.-v. 4. Amino acid neurotransmitters.-v. 5. Synaptic modulators.-v. 6. Biogenic amine receptors.-v. 7. Principles of behavioral pharmacology. 1. Psychopharmacology. I. Iversen, Leslie Lars. II. Iversen, Susan D., 1940- III. Snyder, Solomon H., 1938- [DNLM: 1. Psychopharmacology. QV77 H236j RC483.H36 615.78 75-6851 lSBN-13: 978-1-4613-4216-8 e-lSBN-13: 978-1-4613-4214-4 DOl: 10.1007/978-1-4613-4214-4 © 1977 Plenum Press, New York Softcover reprint of the hardcover 1st edition 1977 A Division of Plenum Publishing Corporation 227 West 17th Street, New York, N.Y. -
“MEDICAL PSYCHOLOGY” Year: III Faculty
INFORMATIONAL REFERENCE FOR STUDENTS OF THE DISCIPLINE “MEDICAL PSYCHOLOGY” Year: III Faculty: medical Approved by methodical counsel of general and medical psychology and pedagogic Department 30.08.2017, proceeding №1 According to the curriculum, Medical psychology study is carried out over a 3d year of study. The object of the course is the study of the foundations of medical psychology in general medical practice. Interdisciplinary connections: the basics of psychology, philosophy, pedago- gy, internal medicine, pediatrics, psychiatry. The program of the course consists of the following thematic modules: 1. General questions of Medical Psychology. 2. Applied aspects of Medical Psychology 1. The purpose and objectives of the course 1.1 The purpose of discipline "Medical Psychology" is studying of: - psychological characteristics of people suffering from various diseases, - methods and techniques of mental disorders diagnosing, - differentiation of psychological phenomena and psychopathological symptoms and syndromes, - psychology of relationships between the patient and health care worker, - ways of prevention, psychological correction and psychotherapy in order to help pa- tients - theoretical aspects of psychosomatic and somatopsychic interinfluence. 1.2. The main objectives of the subject "Medical Psychology" are: • indoctrination in theoretical, methodological fundamentals of Medical Psychology in general medical practice, Psychological diagnostics, Psychological prophylaxis, Psychological counseling and Psychotherapy; forms of -
Before They Called It Psychopharmacology* Heinz E
NEUROPSYCHOPHARMACOLOGY 1993-VOL. 8, NO. 4 291 SPECIAL LECTURE Before They Called It Psychopharmacology* Heinz E. Lehmann, M.D. BEFORE THEY CALLED IT Johns Hopkins, who called the domain of psychophar PSYCHOPHARMACOLOGY macology "certainly very meager." Macht conducted pharmacologic experiments with opium narcotics and It is a great privilege and honor to be here today, giv coal tar analgesics on reaction time, tapping speed, etc., ing the second annual lecture on the history of psy much as Kraepelin as early as 1883 had done in Wundt's chopharmacology. My friend Frank Ayd did such an laboratory with alcohol and caffeine, calling it then Phar admirable job with his lecture last year, on the early macopsychologie (Macht 1920). history, that I have had a hard problem finding gaps W. Freeman, in 1931, wrote a more general paper to fill. What I have finally chosen to do is to trace for in the Journal of the American Medical Association on you some of the early history, complete with anecdotes, what he called psychochemistry, and in 1935 Thorner which preceded our modern notions of psychology and wrote the fIrst paper resembling our modern concept pharmacology and then to tell you something of my of the term with "Psychopharmacology of Sodium own experiences and findings in the psychiatric world Amytal in Catatonia." I will discuss this paper in more of the 1940s and 1950s, a world that was remarkably detail later . After a careful search of the modern litera different and simplistic compared to today. I also in ture, I came to the conclusion that official general use tend to give you a subjective "oral history" of my own of the term psychopharmacology in publications dates stumbling attempts to make some sense out of the only to 1960, following a paper by Ross and Cole enti vague and somewhat chaotic potpourri of ideas and tled "Psychopharmacology," when also psychophar pharmacologic approaches to psychiatric problems a macology appears for the fIrst time as a free-standing half century ago. -
Psychopharmacology, Neuropharmacology & Toxicology Expertise
Psychopharmacology, Neuropharmacology & Toxicology Expertise October 2013 Dr Ken Gillman MBBS Re: MAOI anti-depressant drugs MRC Psych Dear Doctor and Colleague, Expert in A patient who wishes to consider treatment with MAOI anti- Psycho- depressant drugs (e.g. “Parnate”, “Nardil”) has obtained this letter pharmacology from my website. I am Dr Ken Gillman MRCPsych, a retired Serotonin academic & clinical psychiatrist. I have published many papers about toxicity psycho-pharmacology and am internationally acknowledged as an Neuroleptic expert on serotonin syndrome (aka serotonin toxicity) and drug-drug malignant interactions generally. You may verify my publications via the NLM syndrome at: Drug http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&term=Gillman interactions P MAOIs or at Google scholar (which also shows their high citation frequency) at: TCAs http://scholar.google.com.au/citations?user=ea6KeD0AAAAJ&hl=en SSRIs and you can get the free pdf from the British Journal of Pharmacology website of one of my recent major reviews ‘Tricyclic antidepressant pharmacology and therapeutic drug interactions updated’. http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0707253/pdf I have also recently published a review of the MAOIs, ‘Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors. J Clin Psychopharmacol, 2011. 31(1): p. 66-74’ I have had extensive experience of using monoamine oxidase inhibitor (MAOI) drugs (Nardil/phenelzine & Parnate/tranylcypromine) for severe and atypical depression and have written about this since these drugs are somewhat maligned and because reduced knowledge and awareness of them makes many doctors shy away from using them when they might be of considerable utility and benefit. -
Social Work and Neurosciences: Speeches and Theoretical Contributions
ISSN 2411-9563 (Print) European Journal of Social Science August 2018 ISSN 2312-8429 (Online) Education and Research Vol 5 No 2 DOI: 10.2478/ejser-2018-0046 Open Access. © 2018 João Cabral Sacadura and Helena Neves Almeida. This is an open access article licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License Social Work and Neurosciences: Speeches and Theoretical Contributions M.ª João Cabral Sacadura, PhD Student, Catholic University of Portugal and University of Coimbra, Portugal Helena Neves Almeida, PhD Professor and Researcher. Faculty of Psychology and Education Sciences University of Coimbra, Portugal Abstract The concept of “neuroscience” sometimes referred to as “the last frontier of biology” (Squire et al., 2008, p. 3) was introduced in the mid-1960s and is now recognized as a multidisciplinary field that analyzes the nervous system to understand the biological basis of human behavior. The ongoing developments and the arising production regarding the deepening of the structure, functions and functioning of the brain and its interaction with the environment enabled the identification of key elements reaching an unprecedented level of knowledge in the history of humankind. The multidisciplinary scientific approach, including non-clinical areas such as music, philosophy, education, mathematics, economics and physics, has also contributed to its further deepening. In the light of this scenario of interdependencies and disciplinary alliances, the discipline of the social and human sciences – social work – whose subject is conceived “from and for the practice” (Parton, 1996) in the day-to-day work with challenging social problems of various types and with different publics. Therefore, the present article aims to analyze what has been done to date since 2001, namely the input and contributions of authors and researchers in the field as well as to understand the input of neuroscience developments in their education and research.